Cutaneous Lymphoma International Consortium
An overview of the Cutaneous Lymphoma International Consortium's (CLIC) work in developing a prognostic index for mycosis fungoides and Sezary Syndrome - the PROCLIPI Study.
Also an overview of the creation of a CLIC Study Biobank to test potential biomarkers in cutaneous lymphoma patients to give clinical information on prognosis and optimal therapy.
A Q&A sessions followed including:
- Where do donated biopsies go? Informed consent when tissues are used in studies.
- Is it possible to participate in the CLIC study?
- Is there a correlation between the incidence of cutaneous lymphoma and other cancers in the same person?
- Is a mathematical model for predicting disease possible?
Presenters: Julia Scarisbrick, MBChB, FRCP, MD, University Hospital Birmingham; Maarten Vermeer, MD, PhD, Leiden University Medical Centre
Recorded at the 2017 2-Day Patient Conference in New York, NY.
-
Category
No comments found